Pathwork Diagnostics brings in $20mm through private round
Pathwork Diagnostics (develops molecular diagnostics for cancer) has raised $20mm through its second financing round. New investor Abingworth led and was joined by returning backers Prospect Venture Partners, Advent Venture Partners, Novus Ventures, Venrock, and Versant Ventures.
- In Vitro Diagnostics
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com